MangoRx vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

MEDVi beats MangoRx overall, scoring 7.7/10 vs 7.5/10. Choose MangoRx for users who want a multi-service telehealth platform covering . Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side comparison of MangoRx and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.

MangoRx

#27 of 48

7.5/10

Multi-service telehealth platform offering compounded GLP-1 alongside other health services.

Visit MangoRx

Higher Rated

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	MangoRx	MEDVi
Our Score	7.5/10	7.7/10
Starting Price	$299/mo	$299/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Users who want a multi-service telehealth platform covering weight loss and men's health	Users who want a low entry price with oral and injectable compounded options
Ranking	#27	#22

Pros & Cons Compared

MangoRx

Pros

+Oral dissolving tablets exclusively — zero injections for any GLP-1 option
+Publicly traded on NASDAQ (MGRX) — SEC-required financial transparency that private competitors can't match
+Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
+Free 100% online consultation with no video call required

Cons

−$299/mo for oral semaglutide is 2-3x the cost of injectable alternatives at $99-149/mo
−Early-stage public company with limited revenue — stock performance reflects financial uncertainty
−Only oral tablet format available — no injectable options if you want higher bioavailability

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

MEDVi edges out MangoRx with a score of 7.7/10 vs 7.5/10. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose MangoRx if you want: users who want a multi-service telehealth platform covering weight loss and men's health. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither MangoRx nor MEDVi feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review